Matthias Hansen
CTO
Healink
Innsbruck, Austria
On-site
Developing LifeSense, a non-invasive glucose monitoring wearable. Early studies show ~3.4% MARD vs CGM. Responsible for PCB & case. Seeking partners/investors.
CTO
Healink
Innsbruck, Austria
Developing LifeSense, a non-invasive glucose monitoring wearable. Early studies show ~3.4% MARD vs CGM. Responsible for PCB & case. Seeking partners/investors.